Disc Medicine IRON Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $88.91M-2.4% | $91.15M-35.2% | $140.66M+10.5% | $127.34M+3.8% | $122.68M-36.3% | ||
| $641.25M-8.4% | $700.01M+47.3% | $475.26M-9.1% | $522.64M-8.6% | $571.99M— | ||
| $747.46M-7.0% | $803.9M+28.2% | $627.17M-5.2% | $661.59M-6.2% | $705.6M+42.9% | ||
| $1.07M-7.7% | $1.16M-5.6% | $1.23M-4.7% | $1.29M-5.9% | $1.37M+82.4% | ||
| $750.21M-7.0% | $806.88M+28.0% | $630.46M-5.2% | $665.06M-6.2% | $709.27M+42.8% | ||
| $34.4M+17.2% | $29.34M+3.8% | $28.27M+15.1% | $24.55M+7.0% | $22.95M+6.7% | ||
| $31.14M-15.0% | $36.64M+37.0% | $26.74M+29.8% | $20.61M+10.0% | $18.74M-19.6% | ||
| $29.37M+0.7% | $29.16M+0.7% | $28.95M— | —— | —— | ||
| $61.78M-7.9% | $67.05M+17.5% | $57.07M+12.1% | $50.9M+4.1% | $48.9M-8.1% | ||
| $4K0.0% | $4K0.0% | $4K+33.3% | $3K0.0% | $3K0.0% | ||
| -$573.69M-12.4% | -$510.19M-13.5% | -$449.66M-16.1% | -$387.33M-16.6% | -$332.09M-11.4% | ||
| $688.43M-6.9% | $739.83M+29.0% | $573.39M-6.6% | $614.17M-7.0% | $660.36M+48.9% | ||
| $750.21M-7.0% | $806.88M+28.0% | $630.46M-5.2% | $665.06M-6.2% | $709.27M+42.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Disc Medicine's total assets?
- Disc Medicine (IRON) holds $750.2M in total assets, up 5.8% year over year.
- How much debt does Disc Medicine have?
- Disc Medicine carries $31.1M in total debt against $688.4M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Disc Medicine have?
- Disc Medicine holds $88.9M in cash and equivalents.
- Can Disc Medicine cover its short-term obligations?
- Its current ratio is 24.00 — current assets exceed current liabilities.
- Where does Disc Medicine's balance sheet data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.